Skip to main content
Brainsway Ltd. logo

Brainsway Ltd. — Investor Relations & Filings

Ticker · BWAY ISIN · IL0011007189 TA Manufacturing
Open in API
Filings indexed 383 across all filing types
Latest filing 2022-11-30 Major Shareholding Noti…
Country IL Israel
Listing TA BWAY

About Brainsway Ltd.

https://www.brainsway.com/

Brainsway Ltd. is a medical technology company focused on developing and marketing advanced noninvasive neurostimulation treatments for mental health and addictive disorders. The company's core product is its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS™) system, which uses a patented H-coil to stimulate deeper and broader regions of the brain. The technology is designed as a safe and effective non-drug treatment option. The Deep TMS system has received multiple FDA clearances for conditions including Major Depressive Disorder (MDD), anxious depression, and Obsessive-Compulsive Disorder (OCD), for which it was the first noninvasive medical device to receive such clearance. It is also FDA-cleared as an aid for short-term smoking cessation, the first TMS device to be cleared for an addiction indication.

Recent filings

Filing Released Lang Actions
Schedule 13G - David Zacut
Major Shareholding Notification Classification · 100% confidence The document explicitly states it is a "SCHEDULE 13G UNDER THE SECURITIES EXCHANGE ACT OF 1934". Schedule 13G filings are used to report beneficial ownership of more than 5% of a class of a company's voting securities. This type of filing relates to significant share ownership changes or holdings by passive investors, which aligns with the definition for Major Shareholding Notification (MRQ). Although Schedule 13G is a specific SEC form, among the provided options, MRQ (Major Shareholding Notification) is the closest functional equivalent for reporting significant ownership thresholds crossing, distinct from standard periodic reports (10-K, IR) or insider trading reports (DIRS).
2022-11-30 English
Schedule 13G - David Zacut
Director's Dealing Classification · 95% confidence The document is an 'Immediate Report' filed with the Israel Securities Authority (ISA) and the Tel Aviv Stock Exchange (TASE). It explicitly states, 'Attached hereto is a report on *Schedule 13-G David Zacut*'. Schedule 13G filings in the US context relate to beneficial ownership changes by passive investors, which often trigger mandatory disclosure requirements in other jurisdictions. Since this document is very short (1786 characters) and its primary function is to announce the attachment of another specific report (Schedule 13-G), it fits the definition of a Report Publication Announcement (RPA) or a general Regulatory Filing (RNS). Given the specific nature of the attachment (a Schedule 13-G, which is an insider/major shareholder filing), it is most closely related to changes in share ownership or insider activity. However, the document itself is an announcement of the filing, not the filing content itself. Since there is no specific code for 'Schedule 13G filing announcement', and it is announcing the publication of a report, RPA is a strong candidate. Alternatively, since it is a mandatory regulatory disclosure that doesn't fit perfectly into the other specific categories (like 10-K, ER, DIV), RNS (Regulatory Filings) serves as the appropriate fallback for miscellaneous regulatory disclosures. Given the explicit mention of attaching a report, RPA is slightly more precise than RNS, but RNS covers general regulatory announcements well. Schedule 13G is related to share ownership changes, but the document is the announcement, not the change notification itself (like MRQ). I will classify this as RNS as it is a general regulatory filing announcement that doesn't fit the other specific report types, adhering to the 'Menu vs Meal' rule by classifying the announcement rather than the underlying report type.
2022-11-30 English
SCHEDULE 13G-Avner Hagai
Major Shareholding Notification Classification · 100% confidence The document explicitly states it is a "SCHEDULE 13G UNDER THE SECURITIES EXCHANGE ACT OF 1934". Schedule 13G filings are used by passive investors (owning 5% or more of a class of a company's securities) to report their holdings to the SEC. This filing type is not explicitly listed in the provided definitions (AGM-R, 10-K, AR, etc.). However, Schedule 13G is a specific type of regulatory filing related to significant share ownership changes, which aligns most closely with the intent of the 'Major Shareholding Notification' (MRQ) definition, although MRQ usually refers to notifications filed under Section 13(d) or 13(g) of the Exchange Act, which Schedule 13G is. Given the options, and recognizing that this is a mandatory disclosure of significant ownership, MRQ is the most appropriate fit among the choices provided, as it deals with changes in significant share ownership levels. It is not an Earnings Release (ER), Annual Report (10-K), or a Director's Dealing report (DIRS), as it reports passive ownership by an individual, not necessarily a director's personal transaction or a company's financial performance.
2022-11-30 English
SCHEDULE 13G-Avner Hagai
Regulatory Filings Classification · 95% confidence The document explicitly mentions 'Schedule 13-G Avner Hagai' and refers to 'Regulation 4 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000'. Schedule 13G filings in the US context relate to beneficial ownership changes, which often trigger immediate reporting requirements in other jurisdictions like Israel (indicated by ISA and TASE references). However, none of the specific codes (10-K, ER, IR, etc.) directly match a Schedule 13G filing. Schedule 13G is a statement of beneficial ownership, which is a type of insider/major shareholder notification. Given the options, 'Major Shareholding Notification' (MRQ) is the closest fit for a Schedule 13G filing, as it reports changes in significant share ownership levels. Since this is a direct filing/report and not an announcement *about* a report, MRQ is selected over RPA/RNS.
2022-11-30 English
BrainsWay Reports Open Market Stock Purchases by Two Board Members
Director's Dealing Classification · 98% confidence The document is explicitly titled 'FORM 6-K' and is a 'REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934'. The exhibit attached (99.1) is titled 'BrainsWay Reports Open Market Stock Purchases by Two Board Members', and the body details purchases made by the Chairman and an independent Director. This content—insider transactions by directors—directly corresponds to the definition of Director's Dealing (DIRS). Although Form 6-K is a general SEC filing, the specific content dictates the classification over a generic 'RNS' or 'Regulatory Filing'. It is not a full annual report (10-K), an earnings release (ER), or a proxy statement (DEF 14A/PSI).
2022-11-28 English
BrainsWay Reports Open Market Stock Purchases by Two Board Members
Director's Dealing Classification · 98% confidence The document is a short regulatory filing (1888 chars) issued to the Israel Securities Authority and the Tel Aviv Stock Exchange. The title explicitly states "BrainsWay Reports Open Market Stock Purchases by Two Board Members." This content directly relates to personal share transactions by company directors/executives. This aligns perfectly with the definition for Director's Dealing (DIRS). Although it mentions an attached PDF, the core content is the report of insider transactions, making DIRS more specific than a general RPA or RNS.
2022-11-28 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.